Xu, Rongrong
Hu, Xinyi
Sun, Zhirong
Zhu, Xuqin
Tang, Yonghong
Funding for this research was provided by:
the Natural Science Foundation of Shanghai (20ZR1412600)
Article History
Received: 13 November 2022
Accepted: 18 January 2023
First Online: 23 January 2023
Declarations
:
: This study protocol was approved by the Ethics Committee of Fudan University Shanghai Cancer Center (FUSCC), China (protocol number: 2209260–4), and the informed consent was also waived by the Ethics Committee of FUSCC, because of the retrospective nature of the study. All the methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.